139 related articles for article (PubMed ID: 9643088)
1. [Transdermal fentanyl].
Lossignol D; Sternon J
Rev Med Brux; 1998 Apr; 19(2):83-6. PubMed ID: 9643088
[TBL] [Abstract][Full Text] [Related]
2. Calculating the cost for drug treatment including the adverse drug reactions treatment cost (primer for fentanyl TTS in Bulgaria).
Petrova GI; Getov IN
Boll Chim Farm; 2002; 141(2):150-3. PubMed ID: 12135164
[TBL] [Abstract][Full Text] [Related]
3. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
[TBL] [Abstract][Full Text] [Related]
4. Fentanyl transdermal system. Pain management at home.
Woodroffe MA; Hays H
Can Fam Physician; 1997 Feb; 43():268-72. PubMed ID: 9040914
[TBL] [Abstract][Full Text] [Related]
5. Economic evaluation of Durogesic in moderate to severe, nonmalignant, chronic pain in Germany.
Greiner W; Lehmann K; Earnshaw S; Bug C; Sabatowski R
Eur J Health Econ; 2006 Dec; 7(4):290-6. PubMed ID: 16983521
[TBL] [Abstract][Full Text] [Related]
6. Comparison of TTS-fentanyl with sustained-release oral morphine in the treatment of patients not using opioids for mild-to-moderate pain.
van Seventer R; Smit JM; Schipper RM; Wicks MA; Zuurmond WW
Curr Med Res Opin; 2003; 19(6):457-69. PubMed ID: 14594516
[TBL] [Abstract][Full Text] [Related]
7. Transdermal therapeutic fentanyl-system (TTS-F).
Mystakidou K; Katsouda E; Tsilika E; Parpa E; Vlahos L
In Vivo; 2004; 18(5):633-42. PubMed ID: 15523905
[TBL] [Abstract][Full Text] [Related]
8. A research-based guideline for appropriate use of transdermal fentanyl to treat chronic pain.
Wakefield B; Johnson JA; Kron-Chalupa J; Paulsen L
Oncol Nurs Forum; 1998 Oct; 25(9):1505-13. PubMed ID: 9802048
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of safety and efficacy of transdermal therapeutic system-fentanyl in adult patients with gynecological cancer-related pain.
Lorvidhaya V; Katanyoo K; Srisomboon J; Suprapaphorn P; Cheewakriangkrai C
J Med Assoc Thai; 2004 Mar; 87(3):319-25. PubMed ID: 15117050
[TBL] [Abstract][Full Text] [Related]
10. Therapy switching in patients receiving long-acting opioids.
Berger A; Hoffman DL; Goodman S; Delea TE; Seifeldin R; Oster G
Ann Pharmacother; 2004 Mar; 38(3):389-95. PubMed ID: 14742831
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of the fentanyl iontophoretic transdermal system (ITS) and intravenous patient-controlled analgesia (IV PCA) with morphine for pain management following abdominal or pelvic surgery.
Minkowitz HS; Rathmell JP; Vallow S; Gargiulo K; Damaraju CV; Hewitt DJ
Pain Med; 2007; 8(8):657-68. PubMed ID: 18028044
[TBL] [Abstract][Full Text] [Related]
12. Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain.
Benítez-Rosario MA; Feria M; Salinas-Martín A; Martínez-Castillo LP; Martín-Ortega JJ
Cancer; 2004 Dec; 101(12):2866-73. PubMed ID: 15529307
[TBL] [Abstract][Full Text] [Related]
13. Transdermal fentanyl: informed prescribing is essential.
Ross JR; Quigley C
Eur J Pain; 2003; 7(5):481-3. PubMed ID: 12935801
[TBL] [Abstract][Full Text] [Related]
14. Do patients prefer transdermal fentanyl or sustained-release oral morphine for treatment of chronic non-cancer pain?
Heidemann AJ; Seaton TL
J Fam Pract; 2001 Oct; 50(10):897. PubMed ID: 11674896
[No Abstract] [Full Text] [Related]
15. Transdermal fentanyl: new preparation. An alternative to morphine.
Prescrire Int; 1998 Oct; 7(37):137-40. PubMed ID: 10915416
[TBL] [Abstract][Full Text] [Related]
16. Factors influencing quality of life in cancer patients: the role of transdermal fentanyl in the management of pain.
Payne R
Semin Oncol; 1998 Jun; 25(3 Suppl 7):47-53. PubMed ID: 9671331
[TBL] [Abstract][Full Text] [Related]
17. A Phase III study to assess the clinical utility of low-dose fentanyl transdermal system in patients with chronic nonmalignant pain.
Otis J; Rothman M
Curr Med Res Opin; 2006 Aug; 22(8):1493-501. PubMed ID: 16870074
[TBL] [Abstract][Full Text] [Related]
18. [The opioid combination of transdermal fentanyl and sustained release morphine for refractory cancer pain--a case report].
Shinjo T; Okada M
Gan To Kagaku Ryoho; 2005 Nov; 32(12):1997-2000. PubMed ID: 16282744
[TBL] [Abstract][Full Text] [Related]
19. Transdermal fentanyl in cancer patients with moderate-to-severe pain: a prospective examination.
Iconomou G; Viha A; Vagenakis AG; Kalofonos HP
Anticancer Res; 2000; 20(6C):4821-4. PubMed ID: 11205226
[TBL] [Abstract][Full Text] [Related]
20. [Tumor pain. Fentanyl TTS: a transdermal system for tumor pain therapy].
Dtsch Med Wochenschr; 1995 Oct; 120(41 Suppl):1-4. PubMed ID: 9022357
[No Abstract] [Full Text] [Related]
[Next] [New Search]
